Assignee
OCERA THERAPEUTICS INC
US·16 granted patents·8 pending applications·132 citations·filing 2006–2022
Top patents by PatentIndex Score
24 records- 0196US10173964B2L-ornithine phenyl acetate and methods of making thereofOCERA THERAPEUTICS INC·Filed 2017·Granted Jan 8, 2019·9 cites·17 claims
- 0296US9034925B2L-ornithine phenyl acetate and methods of making thereofOCERA THERAPEUTICS INC·Filed 2014·Granted May 19, 2015·27 cites·22 claims
- 0396US8785498B2L-ornithine phenyl acetate and methods of making thereofOCERA THERAPEUTICS INC·Filed 2013·Granted Jul 22, 2014·27 cites·9 claims
- 0495US10550069B2L-ornithine phenyl acetate and methods of making thereofOCERA THERAPEUTICS INC·Filed 2018·Granted Feb 4, 2020·6 cites·17 claims
- 0594US11161802B2L-ornithine phenyl acetate and methods of making thereofOCERA THERAPEUTICS INC·Filed 2020·Granted Nov 2, 2021·3 cites·15 claims
- 0694US9604909B2L-ornithine phenyl acetate and methods of making thereofOCERA THERAPEUTICS INC·Filed 2015·Granted Mar 28, 2017·23 cites·4 claims
- 0794US9260379B2Methods of making L-ornithine phenyl acetateOCERA THERAPEUTICS INC·Filed 2015·Granted Feb 16, 2016·24 cites·17 claims
- 0882US7749497B2Use of adsorbent carbon microspheres for the treatment of irritable bowel syndromeOCERA THERAPEUTICS INC·Filed 2006·Granted Jul 6, 2010·2 cites·19 claims
- 0979US10835506B2Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrateOCERA THERAPEUTICS INC·Filed 2016·Granted Nov 17, 2020·4 cites·17 claims
- 1078US11066352B2Processes of making L-ornithine phenylacetateOCERA THERAPEUTICS INC·Filed 2018·Granted Jul 20, 2021·2 cites·18 claims
- 1177US11219611B2Formulations of L-ornithine phenylacetateOCERA THERAPEUTICS INC·Filed 2016·Granted Jan 11, 2022·4 cites·28 claims
- 1274US9493505B2Macrocyclic modulators of the ghrelin receptorOCERA THERAPEUTICS INC·Filed 2014·Granted Nov 15, 2016·1 cites·16 claims
- 1362US10258602B2Macrocyclic ghrelin receptor modulators and methods of using the sameOCERA THERAPEUTICS INC·Filed 2018·Granted Apr 16, 2019·0 cites·16 claims
- 1460US10040751B2Intermediates for macrocyclic compoundsOCERA THERAPEUTICS INC·Filed 2015·Granted Aug 7, 2018·0 cites·21 claims
- 1557US9949949B2Macrocyclic ghrelin receptor modulators and methods of using the sameOCERA THERAPEUTICS INC·Filed 2016·Granted Apr 24, 2018·0 cites·11 claims
- 1655US2022184014A1Formulations of l-ornithine phenylacetateOCERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1754US9409945B2Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discoveryOCERA THERAPEUTICS INC·Filed 2015·Granted Aug 9, 2016·0 cites·3 claims
- 1853US2022202755A1Formulations of l-ornithine phenylacetateOCERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1944US2022362192A1Dosages and uses of ornithine phenylacetate for treating hyperammonemiaOCERA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2044US2018110824A1Macrocyclic Modulators of the Ghrelin ReceptorOCERA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2141US2009148538A1Use of adsorbent carbon microspheres to treat pouchitisOCERA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2233US2016338982A1Formulations of l-ornithine phenylacetateOCERA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2330US2023201148A1Uses of ornithine phenylacetate for treating hyperammonemiaOCERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2428US2020206174A1Treatment and prevention of neuronal cell loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrateOCERA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OCERA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →